Search Results - "WILLEMZE, Roel"
-
1
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells
Published in The Journal of immunology (1950) (15-08-2006)“…Mesenchymal stem cells (MSCs) are not only able to evade the immune system, but they have also been demonstrated to exert profound immunosuppressive properties…”
Get full text
Journal Article -
2
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Published in Blood (15-09-2006)“…Mesenchymal stem cells (MSCs) are multipotent progenitor cells that have emerged as a promising tool for clinical application. Further clinical interest has…”
Get full text
Journal Article -
3
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
Published in Journal of clinical oncology (20-01-2010)“…This study was performed to examine the characteristics of transplant activity for patients with myelodysplastic syndromes (MDS) older than 50 years within the…”
Get full text
Journal Article -
4
Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Published in Journal of clinical oncology (10-11-2009)“…To compare the antitumor efficacy of three different anthracyclines in combination with cytarabine and etoposide in adult patients with newly diagnosed acute…”
Get full text
Journal Article -
5
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Published in Journal of clinical oncology (10-12-2013)“…This randomized trial evaluated the efficacy and toxicity of sequential gemtuzumab ozogamicin (GO) and standard chemotherapy in older patients with newly…”
Get full text
Journal Article -
6
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients
Published in Haematologica (Roma) (01-01-2020)Get full text
Journal Article Web Resource -
7
Allogeneic Stem-Cell Transplantation in Patients With Waldenström Macroglobulinemia: Report From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Published in Journal of clinical oncology (20-11-2010)“…Allogeneic stem-cell transplantation (alloSCT) is a curative therapeutic option for patients with low-grade lymphoid malignancies. Information regarding…”
Get full text
Journal Article -
8
Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy
Published in Haematologica (Roma) (01-09-2009)“…Laboratory of Experimental Hematology, Leiden University Medical Center, Leiden, The Netherlands Correspondence: Marieke Griffioen, Dept. of Hematology, C2-R,…”
Get full text
Journal Article -
9
Hematopoiesis-Restricted Minor Histocompatibility Antigens HA-1- or HA-2-Specific T Cells Can Induce Complete Remissions of Relapsed Leukemia
Published in Proceedings of the National Academy of Sciences - PNAS (04-03-2003)“…Donor lymphocyte infusion (DLI) into patients with a relapse of their leukemia or multiple myeloma after allogeneic stem cell transplantation (alloSCT) has…”
Get full text
Journal Article -
10
Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission
Published in Journal of clinical oncology (20-08-2009)“…The cell source for autologous stem cell transplantation has shifted from bone marrow (BM) to peripheral blood (PB). In acute myelocytic leukemia (AML), for…”
Get full text
Journal Article -
11
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
Published in Haematologica (Roma) (01-08-2012)“…Since HA-1-specific T cells have been shown to make a significant contribution to the clinical responses in patients with relapsed leukemia, we investigated…”
Get full text
Journal Article -
12
Identical Outcome After Autologous or Allogeneic Genoidentical Hematopoietic Stem-Cell Transplantation in First Remission of Acute Myelocytic Leukemia Carrying Inversion 16 or t(8;21): A Retrospective Study From the European Cooperative Group for Blood and Marrow Transplantation
Published in Journal of clinical oncology (01-07-2008)“…Patients with acute myelocytic leukemia carrying inversion 16 (inv16) or t(8;21) have a better initial response to high-dose cytarabine than patients without…”
Get full text
Journal Article -
13
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
Published in Haematologica (Roma) (01-11-2010)“…Human adenovirus can cause morbidity and mortality in immunocompromised patients after allogeneic stem cell transplantation. Reconstitution of…”
Get full text
Journal Article -
14
Minor histocompatibility antigens in human stem cell transplantation
Published in Experimental hematology (01-09-2003)“…Minor histocompatibility antigens (mHags) play a major role in graft rejection, the induction of detrimental graft-vs-host disease (GVHD), and the development…”
Get full text
Journal Article -
15
Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance
Published in Blood (15-09-2005)“…T-cell tolerance is mandatory for major histocompatibility complex (MHC)-mismatched stem-cell transplantation without cytoreduction. Here, we used a…”
Get full text
Journal Article -
16
Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity
Published in Proceedings of the National Academy of Sciences - PNAS (11-03-2008)“…Patients with hematological malignancies can be successfully treated with HLA-matched T cell-depleted allogeneic stem cell transplantation (alloSCT) and…”
Get full text
Journal Article -
17
Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Published in Best practice & research. Clinical haematology (01-06-2010)“…Donor killer cell immunoglobulin-like receptor (KIR) ligand incompatibility in the graft-versus-host direction is associated with decreased relapse incidence…”
Get full text
Journal Article -
18
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
Published in British journal of haematology (01-03-2001)“…Polycomb group (PcG) proteins are involved in the stable transmittance of the repressive state of their gene targets throughout the cell cycle. Mis‐expression…”
Get full text
Journal Article -
19
The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the Literature
Published in Leukemia & lymphoma (2002)“…Twenty years of published literature was reviewed for chemotherapy regimens used to treat patients with acute myeloid leukemia (AML) in first relapse…”
Get full text
Journal Article -
20
Neutrophils Are Indispensable for Hematopoietic Stem Cell Mobilization Induced by Interleukin-8 in Mice
Published in Proceedings of the National Academy of Sciences - PNAS (30-04-2002)“…The CXC chemokine interleukin-8 (IL-8/CXCL8) induces rapid mobilization of hematopoietic progenitor cells (HPCs). Previously we showed that mobilization could…”
Get full text
Journal Article